Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements,… Read more
Nu Skin Enterprises Inc (NUS) - Net Assets
Latest net assets as of September 2025: $799.79 Million USD
Based on the latest financial reports, Nu Skin Enterprises Inc (NUS) has net assets worth $799.79 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.42 Billion) and total liabilities ($624.61 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $799.79 Million |
| % of Total Assets | 56.15% |
| Annual Growth Rate | 8.46% |
| 5-Year Change | -27.15% |
| 10-Year Change | -21.1% |
| Growth Volatility | 23.21 |
Nu Skin Enterprises Inc - Net Assets Trend (1995–2024)
This chart illustrates how Nu Skin Enterprises Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nu Skin Enterprises Inc (1995–2024)
The table below shows the annual net assets of Nu Skin Enterprises Inc from 1995 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $651.46 Million | -20.74% |
| 2023-12-31 | $821.97 Million | -8.40% |
| 2022-12-31 | $897.30 Million | -1.70% |
| 2021-12-31 | $912.77 Million | +2.07% |
| 2020-12-31 | $894.27 Million | +2.17% |
| 2019-12-31 | $875.29 Million | +11.95% |
| 2018-12-31 | $781.87 Million | +10.97% |
| 2017-12-31 | $704.60 Million | +6.10% |
| 2016-12-31 | $664.07 Million | -19.57% |
| 2015-12-31 | $825.62 Million | -12.40% |
| 2014-12-31 | $942.44 Million | +9.76% |
| 2013-12-31 | $858.62 Million | +45.38% |
| 2012-12-31 | $590.61 Million | +2.85% |
| 2011-12-31 | $574.24 Million | +21.85% |
| 2010-12-31 | $471.25 Million | +25.44% |
| 2009-12-31 | $375.69 Million | +18.82% |
| 2008-12-31 | $316.18 Million | +14.97% |
| 2007-12-31 | $275.01 Million | -13.78% |
| 2006-12-31 | $318.98 Million | -10.05% |
| 2005-12-31 | $354.63 Million | +19.71% |
| 2004-12-31 | $296.23 Million | +2.06% |
| 2003-12-31 | $290.25 Million | -24.90% |
| 2002-12-31 | $386.49 Million | +1.74% |
| 2001-12-31 | $379.89 Million | +3.59% |
| 2000-12-31 | $366.73 Million | +18.53% |
| 1999-12-31 | $309.40 Million | +21.52% |
| 1998-12-31 | $254.60 Million | +43.44% |
| 1997-12-31 | $177.50 Million | +64.66% |
| 1996-12-31 | $107.80 Million | +74.43% |
| 1995-12-31 | $61.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nu Skin Enterprises Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2743.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.71 Billion | 262.79% |
| Common Stock | $91.00K | 0.01% |
| Other Comprehensive Income | $-124.76 Million | -19.15% |
| Total Equity | $651.46 Million | 100.00% |
Nu Skin Enterprises Inc Competitors by Market Cap
The table below lists competitors of Nu Skin Enterprises Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CICOR TECHNOL.NAM. SF 10
F:CRLN
|
$346.09 Million |
|
Beijing Shengtong Printing Co Ltd
SHE:002599
|
$346.10 Million |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
$346.13 Million |
|
MEMBERSH.COLL.GR.A DL-01
F:75Z
|
$346.15 Million |
|
Maxvision Technology Corp
SHE:002990
|
$346.02 Million |
|
SAMPYO Cement Co. Ltd
KQ:038500
|
$346.00 Million |
|
Absci Corp
NASDAQ:ABSI
|
$345.85 Million |
|
Wenzhou Hongfeng Electrical Alloy Co Ltd
SHE:300283
|
$345.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nu Skin Enterprises Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 821,968,000 to 651,455,000, a change of -170,513,000 (-20.7%).
- Net loss of 146,594,000 reduced equity.
- Dividend payments of 11,927,000 reduced retained earnings.
- Share repurchases of 2,063,000 reduced equity.
- Other comprehensive income decreased equity by 24,752,000.
- Other factors increased equity by 14,823,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-146.59 Million | -22.5% |
| Dividends Paid | $11.93 Million | -1.83% |
| Share Repurchases | $2.06 Million | -0.32% |
| Other Comprehensive Income | $-24.75 Million | -3.8% |
| Other Changes | $14.82 Million | +2.28% |
| Total Change | $- | -20.74% |
Book Value vs Market Value Analysis
This analysis compares Nu Skin Enterprises Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.55x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 9.46x to 0.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.77 | $7.27 | x |
| 1996-12-31 | $1.30 | $7.27 | x |
| 1997-12-31 | $2.03 | $7.27 | x |
| 1998-12-31 | $2.93 | $7.27 | x |
| 1999-12-31 | $3.52 | $7.27 | x |
| 2000-12-31 | $4.28 | $7.27 | x |
| 2001-12-31 | $4.53 | $7.27 | x |
| 2002-12-31 | $4.65 | $7.27 | x |
| 2003-12-31 | $3.65 | $7.27 | x |
| 2004-12-31 | $4.08 | $7.27 | x |
| 2005-12-31 | $4.97 | $7.27 | x |
| 2006-12-31 | $4.52 | $7.27 | x |
| 2007-12-31 | $4.19 | $7.27 | x |
| 2008-12-31 | $4.93 | $7.27 | x |
| 2009-12-31 | $5.84 | $7.27 | x |
| 2010-12-31 | $7.30 | $7.27 | x |
| 2011-12-31 | $8.90 | $7.27 | x |
| 2012-12-31 | $9.37 | $7.27 | x |
| 2013-12-31 | $13.97 | $7.27 | x |
| 2014-12-31 | $15.48 | $7.27 | x |
| 2015-12-31 | $13.98 | $7.27 | x |
| 2016-12-31 | $11.84 | $7.27 | x |
| 2017-12-31 | $12.85 | $7.27 | x |
| 2018-12-31 | $13.84 | $7.27 | x |
| 2019-12-31 | $15.65 | $7.27 | x |
| 2020-12-31 | $16.95 | $7.27 | x |
| 2021-12-31 | $17.75 | $7.27 | x |
| 2022-12-31 | $17.76 | $7.27 | x |
| 2023-12-31 | $16.49 | $7.27 | x |
| 2024-12-31 | $13.12 | $7.27 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nu Skin Enterprises Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.46%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 2.25x
- Recent ROE (-22.50%) is below the historical average (24.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 65.05% | 11.21% | 3.03x | 1.91x | $34.02 Million |
| 1996 | 75.79% | 12.04% | 2.05x | 3.08x | $70.92 Million |
| 1997 | 52.73% | 10.51% | 2.53x | 1.99x | $75.85 Million |
| 1998 | 40.81% | 11.37% | 1.51x | 2.38x | $78.44 Million |
| 1999 | 28.02% | 9.70% | 1.39x | 2.08x | $55.76 Million |
| 2000 | 16.82% | 7.01% | 1.49x | 1.61x | $25.03 Million |
| 2001 | 13.24% | 5.68% | 1.52x | 1.53x | $12.32 Million |
| 2002 | 16.78% | 6.73% | 1.58x | 1.58x | $26.19 Million |
| 2003 | 23.39% | 6.88% | 1.58x | 2.15x | $38.85 Million |
| 2004 | 26.22% | 6.83% | 1.87x | 2.06x | $48.05 Million |
| 2005 | 20.88% | 6.27% | 1.74x | 1.91x | $38.57 Million |
| 2006 | 10.29% | 2.94% | 1.68x | 2.08x | $919.00K |
| 2007 | 15.95% | 3.79% | 1.69x | 2.48x | $16.37 Million |
| 2008 | 20.67% | 5.24% | 1.76x | 2.24x | $33.73 Million |
| 2009 | 23.91% | 6.75% | 1.78x | 1.99x | $52.28 Million |
| 2010 | 28.87% | 8.85% | 1.72x | 1.89x | $88.93 Million |
| 2011 | 26.70% | 8.79% | 1.76x | 1.73x | $95.91 Million |
| 2012 | 37.53% | 10.22% | 1.88x | 1.95x | $162.58 Million |
| 2013 | 42.50% | 11.49% | 1.74x | 2.12x | $279.03 Million |
| 2014 | 20.07% | 7.36% | 1.59x | 1.71x | $94.93 Million |
| 2015 | 16.11% | 5.92% | 1.49x | 1.82x | $50.48 Million |
| 2016 | 21.55% | 6.48% | 1.50x | 2.22x | $76.68 Million |
| 2017 | 18.37% | 5.68% | 1.43x | 2.26x | $58.98 Million |
| 2018 | 15.59% | 4.55% | 1.58x | 2.17x | $43.70 Million |
| 2019 | 19.83% | 7.17% | 1.37x | 2.02x | $86.02 Million |
| 2020 | 21.40% | 7.41% | 1.32x | 2.19x | $101.93 Million |
| 2021 | 16.13% | 5.46% | 1.41x | 2.09x | $55.99 Million |
| 2022 | 11.68% | 4.71% | 1.22x | 2.03x | $15.05 Million |
| 2023 | 1.05% | 0.44% | 1.09x | 2.20x | $-73.60 Million |
| 2024 | -22.50% | -8.46% | 1.18x | 2.25x | $-211.74 Million |
Industry Comparison
This section compares Nu Skin Enterprises Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nu Skin Enterprises Inc (NUS) | $799.79 Million | 65.05% | 0.78x | $346.07 Million |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |